Rapport Therapeutics (RAPP) Change in Account Payables (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Change in Account Payables data on file, last reported at $2.3 million in Q1 2026.

• On a quarterly basis, Change in Account Payables rose 1145.95% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 345.53% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 740.17% from the prior year.
• Change in Account Payables for Q1 2026 stood at $2.3 million, up from $1.2 million in the prior quarter.
• Over the last five years, Change in Account Payables for RAPP reached as high as $2.3 million in Q1 2026 and fell as low as -$1.1 million in Q1 2024.
• Historically, Change in Account Payables has averaged $502909.1 across 4 years, with a median of $633000.0 in 2023.
• Across the five-year window, Change in Account Payables sank 489.13% in 2025 and surged 1145.95% in 2026, its largest moves.
• Year by year, Change in Account Payables stood at $725000.0 in 2023, then fell by 10.62% to $648000.0 in 2024, then surged by 81.79% to $1.2 million in 2025, then jumped by 95.67% to $2.3 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were $2.3 million in Q1 2026, $1.2 million in Q4 2025, and -$179000.0 in Q3 2025.